Skip to main content

"The Race Is On: Investor Spurs Discovery of Game-changing Parkinson's Tool" (Fall/Winter 2019)

Read how the “Ken Griffin Alpha-Synuclein Imaging Competition”, a $10-million program, funded in part by a leadership gift of $7.5 million from Ken Griffin, holds potential to transform Parkinson’s drug development. Also, learn more about new treatment options for people living with Parkinson’s disease and how diversity and inclusivity in PD research will offer a more holistic view of the disease.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.